S&P 500 Futures
(0.14%) 5 334.50 points

Dow Jones Futures
(0.07%) 40 167 points

Nasdaq Futures
(0.19%) 18 671 points

Oil
(-0.06%) $80.01

Gas
(1.75%) $2.67

Gold
(0.99%) $2 441.40

Silver
(3.83%) $32.46

Platinum
(0.93%) $1 100.10

USD/EUR
(-0.08%) $0.919

USD/NOK
(-0.13%) $10.66

USD/GBP
(-0.01%) $0.787

USD/RUB
(0.08%) $91.05

Realtime updates for BB Biotech AG [BBZA.DE]

Exchange: XETRA

Last Updated17 May 2024 @ 11:35

25% discount on Stockinvest.us - Use code: Podcast

-0.24% € 42.25

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology...

Stats
Today's Volume	18 949.00
Average Volume	22 885.00
Market Cap	2.33B
EPS	€0 ( 2023-10-20 )
Next earnings date	( €0 ) 2024-07-26
Last Dividend	€2.85 ( 2023-03-27 )
Next Dividend	€0 ( N/A )
P/E	-10.97
ATR14	€0.103 (0.24%)

Volume Correlation

Long: -0.03 (neutral)

Short: -0.70 (moderate negative)

Signal:(48.478) Neutral

BB Biotech AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BB Biotech AG Correlation - Currency/Commodity

0.24
( neutral )

0.25
( neutral )

0.00
( neutral )

0.21
( neutral )

-0.32
( neutral )

-0.36
( neutral )

BB Biotech AG Financials

Annual	2023
Revenue:	€-199.57M
Gross Profit:	€-199.57M (100.00 %)
EPS:	€-3.77

FY	2023
Revenue:	€-199.57M
Gross Profit:	€-199.57M (100.00 %)
EPS:	€-3.77

FY	2022
Revenue:	€-351.23M
Gross Profit:	€-351.23M (100.00 %)
EPS:	€-6.50

FY	2021
Revenue:	€-396.22M
Gross Profit:	€0.00 (0.00 %)
EPS:	€-7.31

Financial Reports:

No articles found.

BB Biotech AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€2.85 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

BB Biotech AG Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.05 - Stable (20.97%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€3.60	2021-03-22
Last Dividend	€2.85	2023-03-27
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	€10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	3.31	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.05
Div. Directional Score	9.28	--

Next Divdend (Est)
(2024-12-31)

€0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

3.31

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
STO3.DE	Ex Dividend Knight	2023-06-22	Annually	0	0.00%
8TRA.DE	Ex Dividend Junior	2023-06-02	Annually	0	0.00%
INN1.DE	Ex Dividend Junior	2023-08-07	Semi-Annually	0	0.00%
WMT.DE	Ex Dividend Knight	2023-12-07	Quarterly	0	0.00%
BLQA.DE	Ex Dividend Knight	2023-09-07	Quarterly	0	0.00%
MLP.DE	Ex Dividend Junior	2023-06-30	Annually	0	0.00%
DEF.DE	Ex Dividend Knight	2023-07-24	Annually	0	0.00%
PEP.DE	Ex Dividend Knight	2023-08-31	Quarterly	0	0.00%
G24.DE	Ex Dividend Junior	2023-06-23	Annually	0	0.00%
HYI.F	No Dividend Player	2023-06-19	Annually	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.915	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.109	1.200	6.37	7.65	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.64	10.00	[0.1 - 1]
payoutRatioTTM	0.356	-1.000	6.44	-6.44	[0 - 1]
currentRatioTTM	7.99	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.97	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.00114	1.500	-1.105	-1.657	[0.2 - 2]
debtRatioTTM	0.122	-1.500	7.97	-10.00	[0 - 0.6]
interestCoverageTTM	65.89	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.576	2.00	9.21	10.00	[0 - 20]
debtEquityRatioTTM	0.139	-1.500	9.44	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.919	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.251	1.000	9.72	9.72	[0.2 - 2]
assetTurnoverTTM	0.119	0.800	-2.54	-2.03	[0.5 - 2]
Total Score				12.51

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.44	1.000	9.35	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.77	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
dividendYielPercentageTTM	4.93	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
payoutRatioTTM	0.356	1.500	6.44	-6.44	[0 - 1]
pegRatioTTM	0.0406	1.500	-3.06	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.257	1.000	6.08	0	[0.1 - 0.5]
Total Score				6.05

BB Biotech AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.